Elanco Animal Health (NASDAQ:ELAN) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 54,173,571 shares, a growth of 54.1% from the February 15th total of 35,150,581 shares. Approximately 75.1% of the shares of the company are sold short. Based on an average daily volume of 12,286,650 shares, the days-to-cover ratio is currently 4.4 days.
Shares of NASDAQ ELAN opened at $30.64 on Friday. Elanco Animal Health has a fifty-two week low of $28.00 and a fifty-two week high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The company had revenue of $799.30 million during the quarter, compared to analyst estimates of $804.07 million. Elanco Animal Health’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.12 earnings per share.
In other news, Director R David Hoover purchased 20,000 shares of Elanco Animal Health stock in a transaction that occurred on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, for a total transaction of $628,600.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
A number of hedge funds and other institutional investors have recently made changes to their positions in ELAN. Focused Wealth Management Inc acquired a new position in Elanco Animal Health in the 4th quarter valued at $32,000. First Hawaiian Bank acquired a new position in Elanco Animal Health in the 4th quarter valued at $35,000. American International Group Inc. acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $48,000. Public Employees Retirement Association of Colorado acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $83,000. Finally, Metropolitan Life Insurance Co. NY acquired a new position in shares of Elanco Animal Health during the 4th quarter worth $112,000.
WARNING: This piece was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4224827/elanco-animal-health-elan-short-interest-up-54-1-in-february.html.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Featured Article: 12b-1 Fees
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.